Buy SGT-25 online

Buy SGT-25 online( 5f-Cumyl-Pinaca)

Curious about SGT‑25 (5F‑CUMYL‑PINACA)? Discover how this ultra‑potent synthetic cannabinoid works, its risks, legality, and why researchers buy from Davechemicals.com.  Buy SGT-25 online (5F‑CUMYL‑PINACA) is a highly potent indazole‑3‑carboxamide synthetic cannabinoid receptor agonist, supplied by Davechemicals.com official website strictly for qualified laboratory research. This compound, also known as CUMYL‑5F‑PINACA, displays sub‑nanomolar activity at CB1 and CB2 receptors, making it suitable only for experienced teams with robust safety protocols.

What Is SGT‑25 (5F‑CUMYL‑PINACA) | Davechemicals.com

SGT‑25, also referred to as 5F‑CUMYL‑PINACA and CUMYL‑5F‑PINACA, is a synthetic cannabinoid from the indazole‑3‑carboxamide family that acts as a powerful CB1 and CB2 receptor agonist. It has been detected in seized herbal mixtures and so‑called C‑liquids, and its extreme potency has been linked to severe intoxications. At Davechemicals.com, we treat SGT‑25 (5F‑CUMYL‑PINACA) as a high‑risk analytical reference standard, aimed at toxicology, forensic and receptor‑binding research only, never for human or animal consumption.

What Is SGT‑25 (5F‑CUMYL‑PINACA) Exactly?

SGT‑25 (5F‑CUMYL‑PINACA) is the compound 1‑(5‑fluoropentyl)‑N‑(2‑phenylpropan‑2‑yl)‑1H‑indazole‑3‑carboxamide, classified as a synthetic cannabinoid receptor agonist. In vitro data indicate sub‑nanomolar EC50 values at the CB1 receptor, which places it among the most potent members of its class.

According to UNODC data on CUMYL‑5F‑PINACA and summarised literature, SGT‑25 has been reported in multiple EU member states and other regions in association with acute adverse events such as agitation, loss of consciousness, and cardiovascular instability. As a result, it is treated as a substance of concern by regulators in the United States, Europe and beyond.

Why Researchers Buy SGT‑25 (5F‑CUMYL‑PINACA) For Sale From Davechemicals.com 🧪

Our team built Davechemicals.com SGT‑25 page to serve advanced labs that require consistent, traceable standards for cannabinoid research. When researchers buy SGT‑25 (5F‑CUMYL‑PINACA) online from us, they are usually working on:

• Receptor binding assays comparing SGT‑25 to other synthetic cannabinoids such as CUMYL‑PINACA.
• Method validation in forensic toxicology, where SGT‑25 appears as a target analyte in seized herbal blends
• Structure‑activity relationship projects alongside materials such as ADB‑FUBINACA, 5F‑UR‑144 and 5F‑MDMB‑2201.

We keep specifications transparent, similar to the approach used by Cayman Chemical’s synthetic cannabinoid standards and reference databases such as DrugBank and Drugs.com.

Chemical Background: How SGT‑25 (5F‑CUMYL‑PINACA) Works

Pharmacologically, SGT‑25 (5F‑CUMYL‑PINACA) behaves as a full agonist at CB1 receptors, unlike Δ9‑THC, which is a partial agonist. Its indazole‑3‑carboxamide core and 5‑fluoropentyl side chain are common motifs in newer synthetic cannabinoids associated with high potency and short onset time.

According to Wikipedia’s 5F‑CUMYL‑PINACA profile and UN documents, the EC50 at human CB1 receptors is below 0.1 nM, with several‑fold selectivity for CB1 over CB2. That potency amplifies the margin for error if used outside a strictly controlled lab environment, which is one reason several jurisdictions classify it under their strictest schedules.

Legal Status Of SGT‑25 (5F‑CUMYL‑PINACA) In UK, USA, EU, Australia, Asia

Regulatory treatment of SGT‑25 (5F‑CUMYL‑PINACA) is harsh in many regions, and any buy SGT‑25 online query must be filtered through local law.

• In the United States, 5F‑CUMYL‑PINACA is listed as a Schedule I controlled substance, following temporary emergency scheduling and subsequent permanent placement in 2022
• In parts of Europe, including Sweden and EU‑level structures, risk assessments have led to control as a hazardous or psychotropic substance.
• Several Asia‑Pacific and Australian jurisdictions now control broad groups of synthetic cannabinoid receptor agonists, which catch SGT‑25 by structure.

According to a recent risk assessment of a closely related synthetic cannabinoid, regulators note that users often have no idea which compound is present or at what dose, which directly raises overdose risk. For that reason, our SGT‑25 (5F‑CUMYL‑PINACA) catalogue is strictly limited to qualified institutional buyers who confirm compliance with local law.

Table 1: Key Technical Facts For SGT‑25 (5F‑CUMYL‑PINACA)

(For readability on mobile, scroll horizontally if needed.)

Property	Detail (Research‑grade)
Chemical name	1‑(5‑fluoropentyl)‑N‑(2‑phenylpropan‑2‑yl)‑1H‑indazole‑3‑carboxamide
Common names	SGT‑25, 5F‑CUMYL‑PINACA, CUMYL‑5F‑PINACA
Class	Synthetic cannabinoid receptor agonist, indazole‑3‑carboxamide family
Receptor activity	Full agonist at CB1, high potency with CB2 activity
Reported EC50 (CB1)	Below 0.1 nM in recombinant systems
Typical research use	Reference standard, method validation, SAR studies
Regulatory trend	Frequently controlled under the highest drug schedules

All information here is summarised from open scientific and regulatory sources, and researchers should cross‑check current data in their jurisdiction.

Why SGT‑25 (5F‑CUMYL‑PINACA) Is Considered High‑Risk

Case reports on synthetic cannabinoids, compiled by agencies and harm reduction platforms such as PsychonautWiki’s synthetic cannabinoid and TripSit, highlight intense adverse effects at low exposure levels. For 5F‑CUMYL‑PINACA specifically, acute intoxications include severe anxiety, confusion, seizures and loss of consciousness.

According to a recent European risk assessment for structurally related 5‑fluorinated cannabinoids, many hospital cases involve mixed products where the true dosage is unknown, which dramatically increases toxicity. Our policy is simple: we do not encourage, condone, or support any human use of SGT‑25 (5F‑CUMYL‑PINACA), and supply is for analytical or in vitro work only.

Comparing SGT‑25 With Other Synthetic Cannabinoids For Research

Many labs that buy SGT‑25 online for research are also working with other cannabinoids available from Davechemicals.com’s official website, such as 5F‑SGT‑151, EG‑018 and AMB‑PINACA.

Platforms like Cayman Chemical catalogue these materials as receptor agonists with varying potency and selectivity, which allows researchers to map trends across chemical families. Combining our catalogue with public references from DrugBank or Wikipedia can help teams build robust SAR datasets.

Table 2: SGT‑25 (5F‑CUMYL‑PINACA) Versus Selected Analogues

Compound	Key structural feature	Relative potency (CB1, qualitative)	Available at Davechemicals.com
SGT‑25 (5F‑CUMYL‑PINACA)	Indazole‑3‑carboxamide, 5‑fluoropentyl tail	Very high, sub‑nanomolar EC50	Yes, SGT‑25 page
CUMYL‑PINACA (SGT‑24)	Non‑fluorinated pentyl tail	High, but lower than 5°F analogue	Noted in the literature only
5F‑MDMB‑PINACA	Methyl ester, tert‑leucinate group	Very high, associated with toxicity	Seen in risk assessments
5F‑SGT‑151	Structurally related fluorinated cannabinoid	High, reported in seized material	Yes, 5F‑SGT‑151
ADB‑FUBINACA	Indazole‑3‑carboxamide, tert‑valinate	Very high, widely reported	Yes, ADB‑FUBINACA

Potency descriptors are qualitative summaries from published receptor data and regulatory reports, and exact activity depends on assay conditions.

Where To Buy SGT‑25 (5F‑CUMYL‑PINACA) Online Safely

If you operate a registered lab in the United Kingdom, United States, Germany, Australia or Asia, and local law allows it, you can request SGT‑25 (5F‑CUMYL‑PINACA) from Davechemicals.com’s official website after verification. Our store also provides related research materials such as 5F‑UR‑144, EG‑018 and 4F‑ADB for broader cannabinoid panels.

We strongly recommend that teams consulting synthesis or pharmacology data cross‑reference with authoritative resources such as DrugBank’s synthetic cannabinoid entries and Drugs.com professional monographs, where applicable. According to a recent pattern observed in risk reports, improper storage and labelling of synthetic cannabinoids have contributed to serious lab incidents, so we emphasise labelling, secure storage and chain‑of‑custody documentation for all SGT‑25 shipments.

 

Safety, Toxicity And Ethical Use Of SGT‑25 (5F‑CUMYL‑PINACA)

Public health bodies and scientific groups consistently flag SGT‑25 (5F‑CUMYL‑PINACA) and similar compounds as substances with high toxicity potential. Reported harms in the literature include acute psychosis, seizures, cardiovascular events and fatalities linked to synthetic cannabinoid mixtures, although attribution to one single compound is often uncertain.

From an ethical standpoint, our position is straightforward: SGT‑25 (5F‑CUMYL‑PINACA) belongs in analytical work and receptor studies, not in human self‑experimentation. Platforms like TripSit and PsychonautWiki explicitly warn about synthetic cannabinoid unpredictability, and our internal policies mirror that caution.

Table 3: Best‑Practice Lab Handling For SGT‑25 (5F‑CUMYL‑PINACA)

Practice	Reason
Store in clearly labelled, sealed containers in a locked cabinet	Reduces accidental exposure and misidentification.
Maintain detailed inventory and chain of custody	Supports audits and regulatory compliance.
Use PPE (gloves, goggles, lab coat) during handling	Minimises dermal or accidental exposure risk.
Restrict access to trained personnel only	Limits mishandling by inexperienced staff.
Use calibrated microbalances and volumetric tools	Prevents accidental overdosing in analytical solutions.
Dispose of waste as hazardous chemical waste	Aligns with environmental and safety regulations.

These points summarise general good practice guidelines derived from risk assessments on synthetic cannabinoids and hazardous chemicals.

Related Research Chemicals At Davechemicals.com 🔗

Researchers who work with SGT‑25 (5F‑CUMYL‑PINACA) often require a wider library of standards, which is why we also stock:

• Stimulant and cathinone materials such as 4‑MeTMP, 4‑MPD, 3‑MMC and MDPV.
• Dissociatives including 3‑MeO‑PCP, 2‑FDCK and N‑ethyl‑ketamine.
• Psychedelic standards such as 5‑MeO‑DMT, 4‑AcO‑DMT fumarate and Mescaline powder.

These internal links help you explore structurally and pharmacologically diverse compounds for cross‑comparison, dose‑response studies and panel screening.

Key Takeaways About SGT‑25 (5F‑CUMYL‑PINACA)

• SGT‑25 (5F‑CUMYL‑PINACA) is an ultra‑potent synthetic cannabinoid receptor agonist with sub‑nanomolar CB1 activity.
• It has a documented track record in seized products and is often controlled at the strictest legal level in multiple regions.
• Davechemicals.com supplies SGT‑25 (5F‑CUMYL‑PINACA) only to vetted, compliant laboratories for non‑clinical research.
• Safety protocols, transparent documentation and up‑to‑date legal knowledge are non‑negotiable when working with this compound.

Frequently Asked Questions About SGT‑25 (5F‑CUMYL‑PINACA) ❓

 What is SGT‑25 (5F‑CUMYL‑PINACA) used for in research?
Laboratories use SGT‑25 (5F‑CUMYL‑PINACA) as a reference standard for analytical chemistry, receptor binding studies and synthetic cannabinoid panels, often alongside similar compounds such as CUMYL‑PINACA and 5F‑MDMB‑PINACA.

 Is SGT‑25 (5F‑CUMYL‑PINACA) legal to buy in the UK, USA, Germany, Australia or Asia?
Many countries, including the United States and several European states, control 5F‑CUMYL‑PINACA under their strictest drug schedules, so legality depends entirely on local law and your institution’s status. Researchers must confirm legal permissions before placing any order.

 How potent is SGT‑25 (5F‑CUMYL‑PINACA) compared with natural cannabis?
According to receptor assays, SGT‑25 (5F‑CUMYL‑PINACA) shows sub‑nanomolar CB1 activity and acts as a full agonist, which means it can be far stronger than THC on a per‑molecule basis. This extreme potency is one reason it is associated with severe toxicity in case reports.

Can SGT‑25 (5F‑CUMYL‑PINACA) be used for human experiments?
No. Regulatory bodies and toxicology literature treat 5F‑CUMYL‑PINACA as a high‑risk substance with serious adverse effects, and there is no medical approval for human administration. Our SGT‑25 products are strictly labelled for non‑clinical research only.

Why should researchers choose Davechemicals.com for SGT‑25 (5F‑CUMYL‑PINACA)?
We focus on consistent quality, discreet and documented shipping and a broad research catalogue that connects SGT‑25 to related standards like 5F‑SGT‑151, AMB‑PINACA and EG‑018, which supports robust comparative studies.

Call To Action: Ready To Order SGT‑25 (5F‑CUMYL‑PINACA) For Your Lab?

If your facility is legally authorised and you understand the risks, you can explore SGT‑25 (5F‑CUMYL‑PINACA) at Davechemicals.com and build a tailored cannabinoid panel with related products such as 5F‑SGT‑151, EG‑018 and AMB‑PINACA. For complex projects in the UK, USA, Germany, Australia or Asia, structure your work around solid safety protocols and cross‑check every data point with trusted references like DrugBank, Drugs.com and Wikipedia’s 5F‑CUMYL‑PINACA entry.

1 2 3 4 5 6 7 8 9 10

Related Products

• Buy 2f-Viminol online
• Buy ADB-BUTINACA online
• 5F-AB-FUPPYCA (AZ-037)

Browse more in Buy cannabinoids online.

Always read the label and use products as directed. Consult a qualified professional where appropriate.